Literature DB >> 32387849

Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection.

Amandine Masseron1, Laurent Poirel2, Linda Falgenhauer3, Can Imirzalioglu4, Julie Kessler5, Trinad Chakraborty4, Patrice Nordmann6.   

Abstract

OXA-244 is a derivative of OXA-48 showing weaker carbapenemase activity, compromising the detection of corresponding producers in clinical laboratories. Since 2017, the Swiss National Reference Center for Emerging Antibiotic Resistance noticed an increased identification of OXA-244-producing Escherichia coli (n=15) within the country. Different methods (biochemical and immunoassay tests, screening culture media) were tested for the detection of OXA-244 producers. Whole genome sequencing was used to investigate the genetic relatedness between the isolates and the genetic structures at the origin of the acquisition of the blaOXA-244 gene. The mSuperCARBA® medium and the NG-Test CARBA5 assay were found to be suitable tools for detecting all OXA-244-producing isolates. Other selective media did not perform optimally. Among the fifteen strains, five sequence types were identified, with ST38 being predominant. The blaOXA-244 gene was located on the chromosome for all isolates. Overall, detection of OXA-244 producers is challenging and specific guidelines must be followed.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenemase; Detection; OXA-244; OXA-48

Mesh:

Substances:

Year:  2020        PMID: 32387849     DOI: 10.1016/j.diagmicrobio.2020.115059

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

Review 1.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

2.  Rapid spread of OXA-244-producing Escherichia coli ST38 in Germany: insights from an integrated molecular surveillance approach; 2017 to January 2020.

Authors:  Katrin Kremer; Rolf Kramer; Bernd Neumann; Sebastian Haller; Niels Pfennigwerth; Guido Werner; Sören Gatermann; Horst Schroten; Tim Eckmanns; Jörg B Hans
Journal:  Euro Surveill       Date:  2020-06

3.  Emergence and Polyclonal Dissemination of OXA-244-Producing Escherichia coli, France.

Authors:  Cecile Emeraud; Delphine Girlich; Rémy A Bonnin; Agnès B Jousset; Thierry Naas; Laurent Dortet
Journal:  Emerg Infect Dis       Date:  2021-04       Impact factor: 6.883

4.  Screening and Characterization of Multidrug-Resistant Enterobacterales among Hospitalized Patients in the African Archipelago of Cape Verde.

Authors:  Samanta Freire; Teresa Grilo; Maria Luísa Teixeira; Euclides Fernandes; Laurent Poirel; Marta Aires-de-Sousa
Journal:  Microorganisms       Date:  2022-07-14

5.  Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.

Authors:  Jacqueline Findlay; Vincent Perreten; Laurent Poirel; Patrice Nordmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-14       Impact factor: 5.103

6.  Emergence of carbapenem-resistant ST131 Escherichia coli carrying bla OXA-244 in Germany, 2019 to 2020.

Authors:  Sybille Welker; Sébastien Boutin; Thomas Miethke; Klaus Heeg; Dennis Nurjadi
Journal:  Euro Surveill       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.